APA

Qian Y., Sun L., Liu Y., Zhang Q., Xu J., Ma Z., Zhang X., Xu H. & Wang Y. (2019). Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. : Frontiers in pharmacology.

Chicago

Qian Yi, Sun Lu-Ning, Liu Yang-Jie, Zhang Qiang, Xu Jiang-Hao, Ma Zeng-Qing, Zhang Xue-Hui, Xu Hao and Wang Yong-Qing. 2019. Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. : Frontiers in pharmacology.

Harvard

Qian Y., Sun L., Liu Y., Zhang Q., Xu J., Ma Z., Zhang X., Xu H. and Wang Y. (2019). Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. : Frontiers in pharmacology.

MLA

Qian Yi, Sun Lu-Ning, Liu Yang-Jie, Zhang Qiang, Xu Jiang-Hao, Ma Zeng-Qing, Zhang Xue-Hui, Xu Hao and Wang Yong-Qing. Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors. : Frontiers in pharmacology. 2019.